Eagle's Eye View: Your Weekly CV Update From ACC.org

By: American College of Cardiology
Listen for free

  • Summary

  • The weekly cardiovascular update from ACC.org Editor-in-Chief Kim Eagle, MD, MACC, covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.
    American College of Cardiology Foundation. All rights reserved.
    Show more Show less
Episodes
  • Risk Stratification in Nonischemic Dilated Cardiomyopathy, 2024 Guideline for Perioperative CV Management for Noncardiac Surgery, Lipoprotein(a) and Cardiovascular Disease

    Risk Stratification in Nonischemic Dilated Cardiomyopathy, 2024 Guideline for Perioperative CV Management for Noncardiac Surgery, Lipoprotein(a) and Cardiovascular Disease
    Sep 25 2024

    In this week’s View, Dr. Eagle looks at risk stratification in nonischemic dilated cardiomyopathy using CMR imaging. He then discusses the recent update of the Guideline for Perioperative CV Management for Noncardiac Surgery. Finally, Dr. Eagle talks about a review article on lipoprotein(a) and CVD.

    Subscribe to Eagle’s Eye View

    Show more Show less
    9 mins
  • Long-Term Outcomes in Pericarditis, Polygenic Risk Score and Predicting CVD, Aortic Disease in Children with FBN1-Related Marfan Syndrome

    Long-Term Outcomes in Pericarditis, Polygenic Risk Score and Predicting CVD, Aortic Disease in Children with FBN1-Related Marfan Syndrome
    Sep 18 2024

    In this week’s View, Dr. Eagle looks at predicting long-term outcomes in patients with recurrent pericarditis. He then explores how the polygenic risk score may add to the clinical risk estimate for predicting cardiovascular disease in populations. Finally, Dr. Eagle discusses the management of aortic disease in children with FBN1-related Marfan syndrome.

    Subscribe to Eagle’s Eye View

    Show more Show less
    11 mins
  • Eight Practice-Changing Trials Featured at ESC Congress 2024

    Eight Practice-Changing Trials Featured at ESC Congress 2024
    Sep 12 2024
    In this special edition of Eagle’s Eye View, Dr. Eagle summarizes the most important trials that were featured at the ESC Congress 2024, August 30 to September 2—eight trials that could have significant influence on your day-to-day practice. They include: FINEARTS-HF, exploring the benefits of finerenone in patients with HFmrEF or HFpEF; SCOFF, asking if fasting prior to cath lab procedures is necessary; SENIOR-RITA on CV management in frail adults; SHAM-PVI, exploring pulmonary vein isolation vs. sham intervention in patients with asymptomatic AFib; ASSURE DES, examining continuing vs. interruptive aspirin therapy before noncardiac surgery in patients with DES; Stop-or-Not, on the continuation vs. discontinuation of RASIs prior to major noncardiac surgery; ABYSS, exploring the impact of interrupting or continuing beta-blocker treatment in patients with a history of MI; and RESHAPE-HF2, on the impact of M-TEER on patients with FMR and symptomatic HF. Subscribe to Eagle’s Eye View
    Show more Show less
    11 mins
Physical Illness & Disease Hygiene & Healthy Living
Show more Show less

What listeners say about Eagle's Eye View: Your Weekly CV Update From ACC.org

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available